Abstract
Proteins therapy is of great importance in the treatment of protein deficiency disease. Most human diseases are related to the malfunctioning of one or more proteins. The most effective and direct approach is protein therapy, which delivers the proteins into the target cell to replace the dysfunction protein and maintain the balance of organism. However, clinical application is frequently hampered by various biological barriers to their successful delivery. This review aims to discuss the recent advances about microparticles and nanoparticles fabricated using micro and nanotechnology for intracellular delivery therapy protein and give some suggestions about the promising delivery system.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
R. Q. Wan, E. C. Noguera and S. R. B. Weis, Neuro. Report. 9, 677–682 (1998). http://dx.doi.org/10.1097/00001756-199803090-00021
W. Wang, Int. J. Pharm. 185, 129 (1999). http://dx.doi.org/10.1016/S0378-5173(99)00152-0
F. Alexis, E. Pridgen, L. K. Molnar and O. C. Farokhzad, Mol. Pharm. 5, 505 (2008). http://dx.doi.org/10.1021/mp800051m
J. Zámečnik, L. Vargová, A. Homola, R. Kodet and E. Syková, Neuropath. Appl. Neuro. 30, 338 (2004). http://dx.doi.org/10.1046/j.0305-1846.2003.00541.x
G. M. D. Guglielmo, C. L. Roy, A. F. Goodfellow and J. L. Wrana, Nat. Cell Biol. 5, 410 (2003). http://dx.doi.org/10.1038/ncb975
A. D. Frankel and C. O. Pabo, Cell, 55, 1189 (1998). http://dx.doi.org/10.1016/0092-8674(88)90263-2
Green, M. Loewenstein and P.M., Cell 55, 1179 (1998). http://dx.doi.org/10.1016/0092-8674(88)90262-0
V. Torchilin, R. Rammohan, V. Weissig and T. Levchenko, Proc. Natl. Acad. Sci. 98, 8786 (2001). http://dx.doi.org/10.1073/pnas.151247498
A. Ho, S. R. Schwarze, S. J. Mermelstein, G. Waksman and S. F. Dowdy, Cancer Res. 61, 474 (2001).
J. Sun, Y. Yan, X. T. Wang, X. W. Liu, D. J. Peng, M. Wang, J. Tian, Y. Q. Zong, Y. H. Zhang, M. H. M. Notebornand S. Qu, Int. J. Cancer 124, 2973 (2009). http://dx.doi.org/10.1002/ijc.24279
A. Ziegler, X. Blatter, A. Seelig and J. Seelig, Biochemistry 42, 9185 (2003). http://dx.doi.org/10.1021/bi0346805
B. Guelen, H. Paterson, J. Gaken, M. Meyers, F. Farzaneh and M. Tavassoli, Oncogene 23, 1153 (2004). http://dx.doi.org/10.1038/sj.onc.1207224
F. R. Formiga, B. Pelacho, E. Garbayo, G. Abizanda, J. J. Gavira, T. Simon-Yarza, M. Mazo, E. Tamayo, C. Jauquicoa, C. Ortiz-de-Solorzano, F. Prósper, and M. J. Blanco-Prieto, J. Control. Release 147, 30 (2010). http://dx.doi.org/10.1016/j.jconrel.2010.07.097
S. Marc, S. Juergen, W. E. Hennink, J. Wim, J. Control. Release. 119, 301 (2007). http://dx.doi.org/10.1016/j.jconrel.2007.03.003
W. Jiang and S. P. Schwendeman, Pharm. Res. 18, 878 (2001). http://dx.doi.org/10.1023/A:1011009117586
A. Jostel, A. Mukherjee, J. Alenfall, L. Smethurst and S. M. Shalet, Clin. Endocrinol. 62, 623 (2007). http://dx.doi.org/10.1111/j.1365-2265.2005.02271.x
A. M. Bratt-Leal, R. L. Carpenedo, M. D. Ungrin, P. W. Zandstra and T. C. McDevitt, Biomaterials 32, 48 (2011). http://dx.doi.org/10.1016/j.biomaterials.2010.08.113
M. L. Tan, P. F. M. Choong, C. R. Dass, Peptides 31, 184 (2010). http://dx.doi.org/10.1016/j.peptides.2009.10.002
W. Yuan, Y. Geng, F. Wu, Y. Liu, M. Guo, H. Zhao and T. Jin, Int. J. Pharm. 366, 154 (2009). http://dx.doi.org/10.1016/j.ijpharm.2008.09.007
W. Yuan, F. Wu and T. Jin, Polym. Adv. Technol. 20, 834 (2009). http://dx.doi.org/10.1002/pat.1338
Y. Geng, W. Yuan, F. Wu, J. Chen, M. He and Y. Jin, J. Control. Release 130, 259 (2008). http://dx.doi.org/10.1016/j.jconrel.2008.06.011
T. B. Drueke, F. Locatelli, N. Clyne, K. U. Eckardt, I. C. Macdougal, D. Tsakiris, H. U. Burger and A. Scherhag, New Eng. J. Med. 355, 2071 (2006). http://dx.doi.org/10.1056/NEJMoa062276
S. V. Vinogradov, T. K. Bronich and A. V. Kabanov, Adv. Drug Deliv. Rev. 54, 135 (2002). http://dx.doi.org/10.1016/S0169-409X(01)00245-9
A. K. Varkouhi, M. Scholte, S. Gert and J. H. Hidde, J. Control. Release (2011). http://dx.doi.org/10.1016/j.jconrel.2010.11.004
P. Calvo, B. Gouritin, H. Chacun, D. Desmaile, J. D’Angelo, J. P. Noel, D. Georgin, E. Fattal, J. P. Andreux and P. Couvreur, Pharm. Res. 18, 157 (2001). http://dx.doi.org/10.1023/A:1010931127745
N. E. Botterhuis, Q. Sun, P. C. M. M. Magusin, R. A. Van Santen and N. A. J. M. Sommerdijk, Chem-Eur. J. 12, 1448 (2006). http://dx.doi.org/10.1002/chem.200500588
C. Y. Lai, B. G. Trewyn, D. M. Jeftinija, K. Jeftinija, S. Xu, S. Jeftinija and V. S. Y. Lin, J. Am. Chem. Soc. 125, 4451 (2003). http://dx.doi.org/10.1021/ja028650l
G. Weissmann and G. Sessa, J. Lipid Res. 9, 310 (1968).
C. R. Dass, T. L. Walker, M. A. Burton, J. Pharm. Pharmacol. 49, 972 (1997). http://dx.doi.org/10.1111/j.2042-7158.1997.tb06025.x
A. E. Porter, M. Gass, K. Muller, J. N. Skepper, P. A. Midgley, M. Welland, Nat. Nanotechnol. 2, 713 (2007). http://dx.doi.org/10.1038/nnano.2007.347
C. C. Lee, J. A. MacKay, J. M. J. Fréchet and F. C. Szoka, Nat. Biotechnol. 23, 1517 (2005). http://dx.doi.org/10.1038/nbt1171
D. W. Pack, A. S. Hoffman, S. Pun and P. S. Stayton, Nat. Rev. Drug. Discov. 4, 581 (2005). http://dx.doi.org/10.1038/nrd1775
O. Boussif, H. F. LezoualC, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix and J. P. Behr, Proc. Natl. Acad. Sci. USA 92, 7297 (1995). http://dx.doi.org/10.1073/pnas.92.16.7297
N. D. Sonawan, R. C. Szoka and A. S. Verkman, J. Biol. Chem. 278, 44826 (2003). http://dx.doi.org/10.1074/jbc.M308643200
M. Yan, J. Du, Z. Gu, M. Liang, Y. Hu, W. Zhang, S. Priceman, L. Wu, Z. H. Zhou, Z. Liu, T. Segura, Y. Tang and Y. Lu, Nat. Nano. 5, 48 (2010). http://dx.doi.org/10.1038/nnano.2009.341
M. A. Yessine, M. Lafleur, C. Meier, H. U. Petereit and J. C. Leroux, BBA — Biomembranes, 1613, 28 (2003).
C. Kusonwiriyawong, P. V. D. Wetering, J. A. Hubbell, H. P. Merkle and E. Walter, Euro. J. Pharm. Biopharm. 56, 237 (2003). http://dx.doi.org/10.1016/S0939-6411(03)00093-6
W. B. Liechtyi, R. Chen, F. Farzaneh, M. Tavassoli and N. K. H. Slater, Adv. Mater. 21, 3910 (2009). http://dx.doi.org/10.1002/adma.200901733
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, D., Hu, Z., Su, J. et al. Micro and Nanotechnology for Intracellular Delivery Therapy Protein. Nano-Micro Lett. 4, 118–123 (2012). https://doi.org/10.1007/BF03353702
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03353702